INVITAE CORP's ticker is NVTA and the CUSIP is 46185L103. A total of 354 filers reported holding INVITAE CORP in Q3 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,800 | -30.8% | 10,222 | -4.7% | 0.00% | -100.0% |
| Q4 2022 | $19,943 | -23.3% | 10,722 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | -53.6% | 10,692 | -53.5% | 0.00% | -50.0% |
| Q2 2022 | $56,000 | -66.7% | 23,012 | +109.1% | 0.00% | -60.0% |
| Q4 2021 | $168,000 | -80.3% | 11,003 | -63.4% | 0.01% | -80.8% |
| Q3 2021 | $854,000 | -18.3% | 30,028 | -3.0% | 0.03% | -16.1% |
| Q2 2021 | $1,045,000 | -24.4% | 30,971 | -14.4% | 0.03% | -29.5% |
| Q1 2021 | $1,383,000 | -5.1% | 36,188 | +3.8% | 0.04% | -12.0% |
| Q4 2020 | $1,457,000 | +16.6% | 34,847 | +20.8% | 0.05% | +2.0% |
| Q3 2020 | $1,250,000 | +16.8% | 28,843 | -18.4% | 0.05% | +4.3% |
| Q2 2020 | $1,070,000 | +236.5% | 35,338 | +51.9% | 0.05% | +147.4% |
| Q1 2020 | $318,000 | -53.4% | 23,260 | -45.0% | 0.02% | -34.5% |
| Q4 2019 | $682,000 | +12.4% | 42,278 | +34.1% | 0.03% | 0.0% |
| Q3 2019 | $607,000 | +10.0% | 31,519 | +34.2% | 0.03% | +3.6% |
| Q2 2019 | $552,000 | +48.8% | 23,478 | +48.3% | 0.03% | +33.3% |
| Q1 2019 | $371,000 | +47.2% | 15,835 | +4.9% | 0.02% | +40.0% |
| Q3 2018 | $252,000 | – | 15,090 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 104,861 | $1,560,000 | 2.11% |
| Baker Brothers Advisors | 6,554,967 | $97,538,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 929,765 | $13,835,000 | 0.58% |
| Camber Capital Management LP | 500,000 | $7,440,000 | 0.51% |
| Rock Springs Capital Management LP | 400,000 | $5,952,000 | 0.43% |
| Redmile Group, LLC | 181,224 | $2,563,000 | 0.21% |
| Perceptive Advisors | 299,583 | $2,306,000 | 0.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $2,480,000 | 0.08% |
| CORRADO ADVISORS, LLC | 11,860 | $176,000 | 0.08% |
| Orbimed Advisors | 456,666 | $6,795,000 | 0.05% |